Fidelity Investments
ITCI

Fidelity Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,662,273
Closed -$351M 5569
2025
Q1
$351M Sell
2,662,273
-8,414,172
-76% -$1.11B 0.02% 589
2024
Q4
$925M Sell
11,076,445
-45,207
-0.4% -$3.78M 0.06% 279
2024
Q3
$814M Sell
11,121,652
-116,146
-1% -$8.5M 0.05% 325
2024
Q2
$770M Buy
11,237,798
+43,185
+0.4% +$2.96M 0.05% 314
2024
Q1
$775M Sell
11,194,613
-263,081
-2% -$18.2M 0.05% 328
2023
Q4
$821M Buy
11,457,694
+477,984
+4% +$34.2M 0.06% 278
2023
Q3
$572M Sell
10,979,710
-203,786
-2% -$10.6M 0.05% 347
2023
Q2
$708M Sell
11,183,496
-756,645
-6% -$47.9M 0.06% 307
2023
Q1
$647M Sell
11,940,141
-88,649
-0.7% -$4.8M 0.06% 331
2022
Q4
$637M Buy
12,028,790
+1,758,793
+17% +$93.1M 0.06% 306
2022
Q3
$478M Sell
10,269,997
-63,066
-0.6% -$2.93M 0.05% 373
2022
Q2
$590M Sell
10,333,063
-621,647
-6% -$35.5M 0.06% 319
2022
Q1
$670M Sell
10,954,710
-7,259
-0.1% -$444K 0.05% 352
2021
Q4
$574M Sell
10,961,969
-119,027
-1% -$6.23M 0.04% 413
2021
Q3
$413M Sell
11,080,996
-1,041,898
-9% -$38.8M 0.03% 501
2021
Q2
$495M Sell
12,122,894
-14,628
-0.1% -$597K 0.04% 434
2021
Q1
$412M Buy
12,137,522
+113,936
+0.9% +$3.87M 0.04% 495
2020
Q4
$382M Buy
12,023,586
+186,244
+2% +$5.92M 0.03% 481
2020
Q3
$304M Buy
11,837,342
+3,307,736
+39% +$84.9M 0.03% 468
2020
Q2
$219M Buy
8,529,606
+786,961
+10% +$20.2M 0.02% 576
2020
Q1
$119M Buy
7,742,645
+1,417,990
+22% +$21.8M 0.02% 694
2019
Q4
$217M Buy
6,324,655
+197,662
+3% +$6.78M 0.02% 620
2019
Q3
$45.8M Sell
6,126,993
-2,143,200
-26% -$16M 0.01% 1200
2019
Q2
$107M Buy
8,270,193
+2,683
+0% +$34.8K 0.01% 880
2019
Q1
$101M Buy
8,267,510
+58,561
+0.7% +$713K 0.01% 904
2018
Q4
$93.5M Buy
8,208,949
+2,708
+0% +$30.8K 0.01% 882
2018
Q3
$178M Buy
8,206,241
+1,784
+0% +$38.7K 0.02% 708
2018
Q2
$145M Buy
8,204,457
+2,390
+0% +$42.2K 0.02% 798
2018
Q1
$173M Buy
8,202,067
+15,424
+0.2% +$325K 0.02% 742
2017
Q4
$119M Buy
8,186,643
+221,383
+3% +$3.21M 0.01% 917
2017
Q3
$126M Buy
7,965,260
+1,452,189
+22% +$22.9M 0.02% 870
2017
Q2
$80.9M Buy
6,513,071
+1,530
+0% +$19K 0.01% 1081
2017
Q1
$106M Buy
6,511,541
+21,305
+0.3% +$346K 0.01% 966
2016
Q4
$97.9M Buy
6,490,236
+2,155
+0% +$32.5K 0.01% 1000
2016
Q3
$98.9M Buy
6,488,081
+3,184
+0% +$48.5K 0.01% 980
2016
Q2
$252M Buy
6,484,897
+8,591
+0.1% +$334K 0.03% 567
2016
Q1
$180M Buy
6,476,306
+22,924
+0.4% +$637K 0.02% 704
2015
Q4
$347M Buy
6,453,382
+165,721
+3% +$8.91M 0.05% 432
2015
Q3
$252M Buy
6,287,661
+1,042,486
+20% +$41.7M 0.04% 522
2015
Q2
$168M Buy
5,245,175
+5,912
+0.1% +$189K 0.02% 789
2015
Q1
$125M Buy
5,239,263
+829,688
+19% +$19.8M 0.02% 930
2014
Q4
$77.8M Buy
4,409,575
+1,567
+0% +$27.7K 0.01% 1132
2014
Q3
$60.4M Buy
4,408,008
+23,847
+0.5% +$327K 0.01% 1214
2014
Q2
$73.9M Buy
4,384,161
+749
+0% +$12.6K 0.01% 1166
2014
Q1
$79.7M Buy
+4,383,412
New +$79.7M 0.01% 1102